Furthermore, MEG3 overexpression was able to re-sensitize A549/DDP cells to cisplatinum in vitro, and the downregulation of MEG3 enhanced sensitivity to cisplatinum in lung cancer cells through activation of the Wnt/β-catenin signaling pathway. This evidence concerns the gene MEG3 and lung carcinoma.